{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T11:05:23Z","timestamp":1770462323305,"version":"3.49.0"},"reference-count":22,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CCID"],"DOI":"10.2147\/ccid.s266036","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T09:00:32Z","timestamp":1646730032000},"page":"395-402","source":"Crossref","is-referenced-by-count":20,"title":["Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis"],"prefix":"10.2147","volume":"Volume 15","author":[{"given":"Jia C","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert G","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa N","family":"Contento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline M","family":"Maher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail","family":"Cline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.bcp.2012.01.001","volume":"83","author":"Schafer","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"ref2","unstructured":"Otezla [Full Prescribing Information]. Celgene Corporation, Summit, NJ. Available from: https:\/\/www.pi.amgen.com\/united_states\/otezla\/otezla_pi_english.pdf. Accessed November 10, 2021."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s40265-015-0439-1","volume":"75","author":"Deeks","year":"2015","journal-title":"Drugs"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jaad.2015.03.049","volume":"73","author":"Papp","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/bjd.14164","volume":"173","author":"Paul","year":"2015","journal-title":"Br J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/jdv.14015","volume":"31","author":"Reich","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jaad.2020.01.072","volume":"83","author":"Van Voorhees","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jaad.2017.01.052","volume":"77","author":"Crowley","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09546634.2020.1801976","author":"Lanna","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1111\/1346-8138.16074","volume":"48","author":"Mu\u00f1oz-Santos","year":"2021","journal-title":"J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.jaad.2020.05.087","volume":"83","author":"Oak","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jaad.2016.02.1164","volume":"75","author":"Bissonnette","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"543944","DOI":"10.3389\/fmed.2020.543944","volume":"7","author":"St\u00e4nder","year":"2020","journal-title":"Front Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/jdv.13918","volume":"31","author":"Tha\u00e7i","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref15","first-page":"801","volume":"16","author":"Strober","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1210\/en.2009-0108","volume":"150","author":"Zhang","year":"2009","journal-title":"Endocrinology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/CLEP.S239511","volume":"12","author":"Hagberg","year":"2020","journal-title":"Clin Epidemiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/14728214.2020.1745773","volume":"25","author":"Balogh","year":"2020","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref19","unstructured":"How much does Otezla\u00ae (APREMILAST) cost?: official Website. Otezla\u00ae (apremilast) - Official Website. Availablr from: https:\/\/www.otezla.com\/plaque-psoriasis-treatment\/how-much-does-otezla-cost. Accessed November 21, 2021."},{"key":"ref20","unstructured":"Paying for ENBREL: the cost of ENBREL and financial support options. Enbrel\u00ae (etanercept). Availablr from: https:\/\/www.enbrel.com\/financial-support. Accessed November 21, 2021."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s13555-021-00659-w","volume":"12","author":"Tanaka","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e0189765","DOI":"10.1371\/journal.pone.0189765","volume":"13","author":"Kromer","year":"2018","journal-title":"PLoS One"}],"container-title":["Clinical, Cosmetic and Investigational Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=78934","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=78934","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T09:00:38Z","timestamp":1646730038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/apremilast-in-the-treatment-of-plaque-psoriasis-differential-use-in-ps-peer-reviewed-fulltext-article-CCID"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":22,"URL":"https:\/\/doi.org\/10.2147\/ccid.s266036","relation":{},"ISSN":["1178-7015"],"issn-type":[{"value":"1178-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}